Type | Description |
---|---|
Definition | mediator complex subunit 19 |
Date | Results | Publications |
---|---|---|
2020-02-29 11:29:00 | Med19 induces autophagy and enhances breast cancer cells resistance to the cytotoxic action of Adriamycin. Moreover, Med19 suppression inhibits autophagy and promotes chemosensitivity by targeting the HMGB1 signaling axis. | 30161287 |
2019-11-30 11:32:00 | High MED19 expression is associated with breast cancer progression. | 30583076 |
2019-11-23 10:57:00 | Med 19 inhibitioncouldreduce migration abilityof prostate cancer PC3 cells by epithelial-mesenchymal transition | 31715665 |
2018-07-14 11:26:00 | The data suggest that Med19 expression correlates with aggressive characteristics of bladder cancer, and Med19 knockdown suppresses the proliferation and migration of cancer cells through down-regulating the Wnt/beta-catenin pathway. | 28631286 |
2018-05-19 11:37:00 | DEK and LCMR1 were demonstrated to cooperate in the inhibition of apoptosis in lung cancer cells. | 28765911 |
Type | IDs |
---|---|
Synonymous | DT2P1G7, LCMR1, MED19AS |
Gene |
UniProtKB-ID:
MED19_HUMAN
UniprotKB:
A0JLT2
UniParc:
UPI00015C73F2,
UPI00000746CC
EMBL:
BC037223,
BC009723,
AY148462,
CH471076
Ensembl:
ENSG00000156603
KO:
hsa:219541
|
Nucleutide sequences |
EMBL-CDS:
EAW73775.1,
AAN16075.1,
AAH37223.1,
AAH09723.1
Ensembl_TRS:
ENST00000645681,
ENST00000337672
|
Protein sequencees |
Ensembl_PRO:
ENSP00000493863,
ENSP00000337340
RefSeq:
NP_703151.3,
NP_001304007.2
|
Others |
UniRef100:
UniRef100_A0JLT2
UniRef90:
UniRef90_A0JLT2
UniRef50:
UniRef50_A0JLT2
UniGene:
Hs.43619
CCDS:
CCDS7966.2,
CCDS86203.1
|